Ignacio Méndez

522 total citations
31 papers, 395 citations indexed

About

Ignacio Méndez is a scholar working on Surgery, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ignacio Méndez has authored 31 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ignacio Méndez's work include Musculoskeletal pain and rehabilitation (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Ignacio Méndez is often cited by papers focused on Musculoskeletal pain and rehabilitation (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Ignacio Méndez collaborates with scholars based in Spain, United Kingdom and United States. Ignacio Méndez's co-authors include Javier López, Mario Gestoso, Francisco M. Kovacs, María Teresa Gil del Real, Nicole Mufraggi, Nawab Qizilbash, Rainel Sánchez-de la Rosa, Pablo Lázaro, Jaime Fernández de Bobadilla and Ignacio Blanco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pain and BMC Public Health.

In The Last Decade

Ignacio Méndez

27 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Méndez Spain 9 159 151 93 53 45 31 395
Rahul K. Dhanda United States 11 77 0.5× 15 0.1× 92 1.0× 50 0.9× 96 2.1× 17 585
T.L González Spain 4 207 1.3× 40 0.3× 16 0.2× 23 0.4× 15 0.3× 10 370
Manigandan Chockalingam India 12 18 0.1× 32 0.2× 28 0.3× 38 0.7× 18 0.4× 28 339
Jennifer Hastings United States 9 20 0.1× 55 0.4× 46 0.5× 82 1.5× 198 4.4× 22 423
Nebojša Ladjević Serbia 12 67 0.4× 37 0.2× 25 0.3× 106 2.0× 20 0.4× 43 407
Robert Ślusarz Poland 9 19 0.1× 19 0.1× 30 0.3× 43 0.8× 16 0.4× 93 318
Joy R. Karges-Brown United States 8 25 0.2× 29 0.2× 41 0.4× 107 2.0× 26 0.6× 15 373
Phillip J. Mease United States 6 147 0.9× 25 0.2× 18 0.2× 11 0.2× 10 0.2× 10 390
Abhishek R. Payal United States 12 24 0.2× 28 0.2× 58 0.6× 41 0.8× 15 0.3× 23 600
J F Haverman Netherlands 6 193 1.2× 23 0.2× 17 0.2× 10 0.2× 11 0.2× 8 414

Countries citing papers authored by Ignacio Méndez

Since Specialization
Citations

This map shows the geographic impact of Ignacio Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Méndez more than expected).

Fields of papers citing papers by Ignacio Méndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Méndez. The network helps show where Ignacio Méndez may publish in the future.

Co-authorship network of co-authors of Ignacio Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Méndez. A scholar is included among the top collaborators of Ignacio Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Méndez. Ignacio Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Qizilbash, Nawab, Heather Jarman, Ben Bloom, et al.. (2023). Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study. BMC Emergency Medicine. 23(1). 100–100. 1 indexed citations
3.
Mohanty, Salini, Thomas Weiß, Ian R. Matthews, et al.. (2023). Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England. BMC Public Health. 23(1). 201–201. 16 indexed citations
4.
Patel, Hina, Thanh G.N. Ton, Simon Fear, et al.. (2021). Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union. Pharmaceutical Medicine. 35(6). 339–351.
5.
Méndez, Ignacio, et al.. (2020). Poliadenopatías de origen reumatológico y las claves del diagnóstico diferencial: Análisis de 19 casos. Revista médica de Chile. 148(3). 320–326.
6.
Artime, Esther, Irene M. Shui, Ignacio Méndez, et al.. (2019). Pre/post effectiveness evaluation of updated additional risk minimisation measures for an orphan disease: Myozyme (alglucosidase alfa) Safety Information Packet. Pharmacoepidemiology and Drug Safety. 29(1). 103–110. 2 indexed citations
7.
Haro, Josep María, Carlo Altamura, Ricardo Corral, et al.. (2018). Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study. Psychiatry Research. 267. 56–62. 27 indexed citations
8.
Gisbert, Javier P., Fernando Gomollón, & Ignacio Méndez. (2015). Evaluación de coste-efectividad mediante análisis teórico de minimización de costes del uso de dos mesalazinas gastrorresistentes de liberación prolongada en el manejo de la colitis ulcerosa en España. Gastroenterología y Hepatología. 39(3). 199–212. 3 indexed citations
9.
Qizilbash, Nawab, Ignacio Méndez, & Rainel Sánchez-de la Rosa. (2012). Benefit–Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis. Clinical Therapeutics. 34(1). 159–176.e5. 23 indexed citations
10.
Qizilbash, Nawab & Ignacio Méndez. (2011). Trends in utilization and off-label use of polyethylene glycol 4000 laxatives and the prevalence of constipation in children in France. Clinical and Experimental Gastroenterology. 4. 181–181. 6 indexed citations
11.
Arribas, José Ramón, Federico Pulido, Pablo Lázaro, & Ignacio Méndez. (2011). Estudio farmacoeconómico de lopinavir/ritonavir en monoterapia en el ensayo clínico OK04. 8(3). 85–98. 1 indexed citations
12.
Méndez, Ignacio, et al.. (2009). Calidad de vida en lactantes nacidos prematuros según ingresos por infección respiratoria. Anales de Pediatría. 73(3). 121–131. 12 indexed citations
13.
14.
Alonso, Rodrigo, Jaime Fernández de Bobadilla, Ignacio Méndez, et al.. (2008). Cost-Effectiveness of Managing Familial Hypercholesterolemia Using Atorvastatin-Based Preventive Therapy. Revista Española de Cardiología (English Edition). 61(4). 382–393. 13 indexed citations
15.
16.
Méndez, Ignacio, et al.. (2006). Hipotiroidismo congénito. Manifestaciones clínicas en niños menores de 15 semanas con tamiz neonatal positivo. 73(6). 272–279. 1 indexed citations
17.
Méndez, Ignacio, et al.. (2003). Methods of the National Nutrition Survey 1999. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2 indexed citations
18.
Kovacs, Francisco M., Mario Gestoso, María Teresa Gil del Real, et al.. (2003). Risk factors for non-specific low back pain in schoolchildren and their parents: a population based study. Pain. 103(3). 259–268. 199 indexed citations
19.
Vidal, Antonio, et al.. (2003). A note on upgrading long-period seismographs. Geofísica Internacional. 42(1). 53–59. 1 indexed citations
20.
Gil, Francisco, Ignacio Méndez, Agustina Sirgo, et al.. (2003). Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: A brief report on a Spanish cohort. Psycho-Oncology. 12(8). 821–827. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahul K. Dhanda Breakdown of academic impact, for papers by T.L González Breakdown of academic impact, for papers by Manigandan Chockalingam Breakdown of academic impact, for papers by Jennifer Hastings Breakdown of academic impact, for papers by Nebojša Ladjević Breakdown of academic impact, for papers by Robert Ślusarz Breakdown of academic impact, for papers by Joy R. Karges-Brown Breakdown of academic impact, for papers by Phillip J. Mease Breakdown of academic impact, for papers by Abhishek R. Payal Breakdown of academic impact, for papers by J F Haverman
Rankless by CCL
2026